References
- Abbas A.K., Lichtman A.H., Pober J.S.: Cellular and molecular immunology, wyd. 4., W.B. Saunders Company, Philadelphia, 2000
- Abraham E.: Unraveling the role of high mobility group box protein 1 in severe trauma. Critical Care, 13, 1004 (2009)
- Ahrens S., Schulz O. i wsp.: F-actin is an evolutionarily conserved damage-associated molecular pattern recognized by DNGR-1, a receptor for dead cells. Immunity, 36, 635–645 (2012)
- Apetoh L., Zitvogel L. i wsp.: The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy. Immunol. Rev.220, 47–59 (2007)
- Banjara M., Ghosh C.: Sterile Neuroinflammation and Strategies for Therapeutic Intervention. Int. J. Inflam.2017, 8385961 (2017)
- Bianchi M.E.: DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leuk. Biol.81, 1–5 (2007)
- Billingham R.E., Brent L., Medawar P.B.: Actively acquired tolerance of foreign cells. Nature, 172, 603–606 (1953)
- Biragyn A., Kwak L.W. i wsp.: Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science, 298, 1025–1029 (2002)
- Birger Y., Catez F., Furusawa T., Lim J.H., Prymakowska-Bosak M., West K.L., Postnikov Y.V., Haines D.C., Bustin M.: Increased tumorigenicity and sensitivity to ionizing radiation upon loss of chromosomal protein HMGN1. Cancer Res.65, 6711–6718 (2005)
- Bonawitz N.D., Clayton D.A., Shadel G.S.: Initiation and beyond: multiple functions of the human mitochondrial transcription machinery. Mol. Cell. 24, 813–825 (2006)
- Bonilla W.V., Pinschewer D.D. i wsp.: The alarmin interleukin-33 drives protective antiviral CD8+ T cell responses. Science, 335, 984–989 (2012)
- Borges T.J., Lang B.J., Lopes R.L., Bonorino C.: Modulation of alloimmunity by heat shock proteins. Front. Immunol. 7, 303 (2016)
- Burnet F.M.: Immunological recognition of self. Nobel Lecture, (1960)
- Burnet F.M., Fenner F.: The production of antibodies, wyd. 2, Macmillan, Melbourne, 1949
- Burnstock G., Fredholm B.B., North R.A., Verkhratsky A.: The birth and postnatal development of purinergic signalling. Acta Physiol. 199, 93–147 (2010)
- Busso N., So A.: Mechanisms of inflammation in gout. Arthritis Res. Ther. 12, 206 (2010)
- Calderwood S.K., Stevenson M.A., Murshid A.: Heat shock proteins, autoimmunity and cancer treatment. Autoimmune Dis. 2012, 486069 (2012)
- Carp H.: Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils. J. Exp. Med. 155, 264–275 (1982)
- Chotjumlong P., Bolscher J.G., Nazmi K., Reutrakul V., Supanchart C., Buranaphatthana W., Krisanaprakornkit S.: Involvement of the P2X7 purinergic receptor and c-Jun N-terminal and extracellular signal-regulated kinases in cyclooxygenase-2 and prostaglandin E2 induction by LL-37. J. Innate Immun. 5, 72–83 (2013)
- Cohen I., Rider P., Carmi Y., Braiman A., Dotan S., White M.R., Voronov E., Martin M.U., Dinarello C.A., Apte R.N.: Differential release of chromatin-bound IL-1alpha discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammation. Proc. Natl. Acad. Sci. USA, 107, 2574–2579 (2010)
- Cohen E.S., Mustelin T. i wsp.: Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation. Nat. Commun. 6, 8327 (2015)
- Da Rocha A.B., Regner A. i wsp.: Serum Hsp70 as an early predictor of fatal outcome after severe traumatic brain injury in males. J. Neurotrauma, 22, 966–977 (2005)
- Duprez L., Takahashi N., van Hauwermeiren F., Vandendriessche B., Goossens V.: RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome. Immunity,35, 908–918 (2011)
- Działo J., Tokarz-Deptuła B., Deptuła W.: Excitotoxicity and Wallerian degeneration as a processes related to cell death in nervous system. Arch. Ital. Biol. 151, 67–75 (2013)
- Eil R., Restifo N.P. i wsp.: Ionic immune suppression within the tumour microenvironment limits T cell effector function. Nature, 537, 539–543 (2016)
- Ellerman J.E., Brown C.K., de Vera M., Zeh H.J., Billiar T., Rubartelli A., Lotze M.T.: Masquerader: high mobility group box-1 and cancer. Clin. Cancer Res. 13, 2836–2848 (2007)
- Elliott M.R., Koster K.M., Murphy P.S.: Efferocytosis signaling in the regulation of macrophage inflammatory responses. J. Immunol. 198, 1387–1394 (2017)
- Faist E., Wichmann M.W.: Immunology in the severely injured. Der Chirurg, 68, 1066–1070 (1997)
- Fucikova J., Spisek R. i wsp.: Prognostic and predictive value of DAMPs and DAMP – associated processes in cancer. Front. Immunol. 6, 402 (2015)
- Gallucci S., Lolkema M., Matzinger P.: Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 5, 1249–1255 (1999)
- Galluzzi L., Kepp O., Kroemer G.: Mitochondria: master regulators of danger signalling. Nat. Rev. Mol. Cell Biol. 13, 780–788 (2012)
- Ganguly D., Chamilos G., Lande R., Gregorio J., Meller S., Facchinetti V., Homey B., Barrat F.J., Zal T., Gilliet M.: Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J. Exp. Med. 206, 1983–1994 (2009)
- Garg A.D., Agostinis P.: Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses. Immunol. Rev. 280, 126–148 (2017)
- Garg A.D., Agostinis P. i wsp.: Molecular and translational classifications of DAMPs in immunogenic cell death. Front. Immunol. 6, 588 (2015)
- Garg A.D., Agostinis P. i wsp.: A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death. EMBO J. 31, 1062–1079 (2012)
- Ghavami S., Kerkhoff C., Los M., Hashemi M., Sorg C., Karami-Tehrani F.: Mechanism of apoptosis induced by S100A8/A9 in colon cancer cell lines: the role of ROS and the effect of metal ions. J. Leukoc. Biol. 76, 169–175 (2004)
- Goh F.G., Piccinini A.M., Krausgruber T., Udalova I.A., Midwood K.S.: Transcriptional regulation of the endogenous danger signal tenascin-C: a novel autocrine loop in inflammation. J. Immunol. 184, 2655–2662 (2010)
- Grasset E.K., Duhlin A., Agardh H.E., Ovchinnikova O., Hägglöf T., Forsell M.N., Paulsson-Berne G., Hansson G.K., Ketelhuth D.F., Karlsson M.C.: Sterile inflammation in the spleen during atherosclerosis provides oxidation-specific epitopes that induce a protective B-cell response. Proc. Natl. Acad. Sci. USA, 112, 2030–2038 (2015)
- Hangai S., Ao T., Kimura Y., Matsuki K., Kawamura T., Negishi H., Nishio J., Kodama T., Taniguchi T., Yanai H.: PGE2 induced in and released by dying cells functions as an inhibitory DAMP. Proc. Natl. Acad. Sci. USA, 113, 3844–3849 (2016)
- Harris H.E., Andersson U., Pisetsky D.S.: HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease. Nat. Rev. Rheumatol. 8, 195–202 (2012)
- Hirsiger S., Simmen H.P., Werner C.M., Wanner G.A., Rittirsch D.: Danger signals activating the immune response after trauma. Mediators Inflamm. 2012, 315941 (2012)
- Hodzic Z., Schill E.M., Bolock A.M., Good M.: IL-33 and the intestine: The good, the bad, and the inflammatory. Cytokine, 100, 1–10 (2017)
- Hoque R., Farooq A., Mehal W.Z.: Sterile inflammation in the liver and pancreas. J. Gastroenterol. Hepatol.28, 61–67 (2013)
- Howell M.D., Gallo R.L., Boguniewicz M., Jones J.F., Wong C., Streib J.E., Leung D.Y.: Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity, 24, 341–348 (2006)
- Huang H., Tsung A. i wsp.: Endogenous histones function as alarmins in sterile inflammatory liver injury through Toll-like receptor 9 in mice. Hepatology, 54, 999–1008 (2011)
- Huynh M.L., Fadok V.A., Henson P.M.: Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J. Clin. Invest. 109, 41–50 (2002)
- Iyer S.S., Sutterwala F.S. i wsp.: Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc. Natl. Acad. Sci. USA, 106, 20388 (2009)
- Jouault T., El Abed-El Behi M., Martínez-Esparza M., Breuilh L., Trinel P.A., Chamaillard M., Trottein F., Poulain D.: Specific recognition of Candida albicans by macrophages requires galectin-3 to discriminate Saccharomyces cerevisiae and needs association with TLR2 for signaling. J. Immunol. 177, 4679–4687 (2006)
- Klune J.R., Dhupar R., Cardinal J., Billiar T.R., Tsung A.: HMGB1: endogenous danger signaling. Mol. Med. 14, 476–484 (2008)
- Kono H., Rock K.L.: How dying cells alert the immune system to danger. Nat. Rev. Immunol. 8, 279 (2008)
- Korbelik M., Banáth J., Sun J., Canals D., Hannun Y.A., Separovic D.: Ceramide and sphingosine-1-phosphate act as photodynamic therapy-elicited damage-associated molecular patterns: cell surface exposure. Int. Immunopharmacol. 20, 359–365 (2014)
- Krispin A., Bledi Y., Atallah M., Trahtemberg U., Verbovetki I., Nahari E., Zelig O., Linial M., Mevorach D.: Apoptotic cell thrombospondin-1 and heparin-binding domain lead to dendritic-cell phagocytic and tolerizing states. Blood, 108, 3580–3589 (2006)
- Krysko D.V., Garg A.D., Kaczmarek A., Krysko O., Agostinis P., Vandenabeele P.: Immunogenic cell death and DAMPs in cancer therapy. Nat. Rev. Cancer. 12, 860–875 (2012)
- Kumar H., Bot A.: In this tissue: Innate immunity and infectious diseases-an update. Int. Rev. Immunol. 36, 55–56 (2017)
- Kumar H., Kawai T., Akira S.: Pathogen recognition by the innate immune system. Int. Rev. Immunol. 30, 16–34 (2011)
- Kumar J., Okada S., Clayberger C., Krensky A.M.: Granulysin: a novel antimicrobial. Expert Opin Investig Drugs, 10, 321–329 (2001)
- Lam N.Y., Rainer T.H., Chiu R.W., Joynt G.M., Lo Y.M.: Plasma mitochondrial DNA concentrations after trauma. Clin. Chem. 50, 213–216 (2004)
- Lauber K., Wesselborg S. i wsp.: Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell, 113, 717–730 (2003)
- Lenz A., Franklin G.A., Cheadle W.G.: Systemic inflammation after trauma. Injury, 38, 1336–1345 (2007)
- Liu Z.X., Han D., Gunawan B., Kaplowitz N.: Neutrophil depletion protects against murine acetaminophen hepatotoxicity. Hepatology, 43, 1220 (2006)
- Majno G., Joris I.: Apoptosis, oncosis, and necrosis. An overview of cell death. Am. J. Pathol. 146, 3–15 (1995)
- Martin N.T., Martin M.U.: Interleukin 33 is a guardian of barriers and a local alarmin Nat. Immunol. 17, 122–131 (2016)
- Matzinger P.: Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12, 991–1045 (1994)
- Matzinger P.: An innate sense of danger. Semin. Immunol. 10, 399–415 (1998)
- Matzinger P.: The danger model: a renewed sense of self. Science, 296, 301–305 (2002)
- McDonald B., Pittman K., Menezes G.B., Hirota S.A., Slaba I., Waterhouse C.C., Beck P.L., Muruve D.A., Kubes P.: Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science, 330, 362–366 (2010)
- Meisner M., Tschaikowsky K., Hutzler A., Schick C., Schüttler J.: Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med. 24, 680–684 (1998)
- Michaud M., Kroemer G. i wsp.: Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science, 334, 1573–1577 (2011)
- Muller S., Scaffidi P., Degryse B., Bonaldi T., Ronfani L.: New EMBO members’ review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal. EMBO J. 20, 4337–4340 (2001)
- Niedźwiedzka-Rystwej P., Deptuła W.: Defensins: An important innate element of the immune system in mammals. Post. Hig. Med. Dosw. 62, 524–529 (2008)
- Niyonsaba F., Someya A., Hirata M., Ogawa H., Nagaoka I.: Evaluation of the efects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells. Eur. J. Immunol. 31, 1066–1075 (2001)
- Nishiya T., DeFranco A.L.: Ligand-regulated chimeric receptor approach reveals distinctive subcellular localization and signaling properties of the Toll-like receptors. J. Biol. Chem. 279, 19008–19017 (2004)
- Obeid M., Kroemer G. i wsp.: Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat. Med. 13, 54–61 (2007)
- Oka T., Otsu K. i wsp.: Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature, 485, 251–255 (2012)
- Osterloh A., Breloer M.: Heat shock proteins: linking danger and pathogen recognition. Med. Microbiol. Immunol. 197, 1–8 (2008)
- Page R.C., Engel L.D., Narayanan A.S., Clagett J.A.: Chronic inflammatory gingival and periodontal disease. JAMA, 240, 545–550 (1978)
- Pletjushkina O.Y., Skulachev V.P. i wsp.: Long-distance apoptotic killing of cells is mediated by hydrogen peroxide in a mitochondrial ROS-dependent fashion. Cell Death Differ. 12, 1442–1444 (2005)
- Ptak W., Ptak M., Płytycz B.: Co rozpoznaje układ immunologiczny? Na drodze do nowego paradygmatu. Kosmos, 2–3, 149–156 (2003)
- Pullerits R., Bokarewa M., Jonsson I.M., Verdrengh M., Tarkowski A.: Extracellular cytochrome c, a mitochondrial apoptosis-related protein, induces arthritis. Rheumatology, 44, 32–39 (2005)
- Power C., Fanning N., Redmond H.P.: Cellular apoptosis and organ injury in sepsis: a review. Shock, 18, 197–211 (2002)
- Prohászka Z., Singh M., Nagy K., Kiss E., Lakos G., Duba J., Füst G.: Heat shock protein 70 is a potent activator of the human complement system. Cell Stress Chaperones, 7, 17–22 (2002)
- Raoof M., Zhang Q., Itagaki K., Hauser C.J.: Mitochondrial peptides are potent immune activators that activate human neutrophils via FPR-1. J. Trauma, 68, 1328–1332 (2010)
- Raucci A., Palumbo R., Bianchi M.E.: HMGB1: a signal of necrosis. Autoimmunity, 40, 285–289 (2007)
- Ren B., Zou G., Huang Y., Xu G., Xu F., He J., Zhu H., Yu P.: Serum levels of HSP70 and other DAMP proteins can aid in patient diagnosis after traumatic injury. Cell Stress Chaperones, 21, 677–686 (2016)
- Riddell J.R., Wang X.Y., Minderman H., Gollnick S.O.: Peroxiredoxin 1 stimulates secretion of proinflammatory cytokines by binding to TLR4. J. Immunol. 184, 1022–1030 (2010)
- Rittirsch D., Ward P.A. i wsp.: Functional roles for C5a receptors in sepsis. Nat. Med. 14, 551–557 (2008)
- Rondas D., Mathieu C. i wsp.: Citrullinated glucose-regulated protein 78 is an autoantigen in type 1 diabetes. Diabetes, 64, 573–586 (2015)
- Rovlias A., Kotsou S.: The blood leukocyte count and its prognostic significance in severe head injury. Surg. Neurol. 55, 190–196 (2001)
- Schaefer L.: Extracellular matrix molecules: endogenous danger signals as new drug targets in kidney diseases. Curr. Opin. Pharmacol. 10, 185–190 (2010)
- Segal A.W.: How neutrophils kill microbes. Annu. Rev. Immunol. 23, 197–223 (2005)
- Sha Y., Zmijewski J., Xu Z., Abraham E.: HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J. Immunol. 180, 2531–2537 (2008)
- Shi Y., Evans J.E., Rock K.L.: Molecular identification of a danger signal that alerts the immune system to dying cells. Nature, 425, 516–521 (2003)
- Sorice M., Circella A., Cristea I.M., Garofalo T., Di Renzo L., Alessandri C., Valesini G., Esposti M.D.: Cardiolipin and its metabolites move from mitochondria to other cellular membranes during death receptor-mediated apoptosis. Cell Death Differ. 11, 1133–1145 (2004)
- Tesniere A., Apetoh L., Ghiringhelli F., Joza N., Panaretakis T., Kepp O., Schlemmer F., Zitvogel L., Kroemer G.: Immunogenic cancer cell death: a key-lock paradigm. Curr. Opin. Immunol. 20, 504–511 (2008)
- Tesniere A., Panaretakis T., Kepp O., Apetoh L., Ghiringhelli F., Zitvogel L., Kroemer G.: Molecular characteristics of immunogenic cancer cell death. Cell Death Differ. 15, 3–12 (2008)
- Tschopp J., Schroder K.: NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production? Nat. Rev. Immunol. 10, 210 (2010)
- Tsung A., Sahai R., Tanaka H., Nakao A., Fink M.P., Lotze M.T., Yang H., Li J., Tracey K.J., Geller D.A., Billiar T.R.: The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J. Exp. Med. 201, 1135–1143 (2005)
- Walko T.D. III, Bola R.A., Hong J.D., Au A.K., Bell M.J., Kochanek P.M., Clark R.S., Aneja R.K.: Cerebrospinal fluid mitochondrial DNA: a novel DAMP in pediatric traumatic brain injury. Shock, 41, 499–503 (2014)
- Wallin I.E.: A note on the morphology of bacteria symbiotic in the tissues of higher organisms. J. Bacteriol. 7, 471–474 (1922)
- Wallin R.P., Lundqvist A., Moré S.H., von Bonin A., Kiessling R., Ljunggren H.G.: Heat-shock proteins as activators of the innate immune system. Trends Immunol. 23, 130–135 (2002)
- Wang H., Tracey K.J. i wsp.: HMG-1 as a late mediator of endotoxin lethality in mice. Science, 285, 248–251 (1999)
- Wang H., Yang H., Tracey K.J.: Extracellular role of HMGB1 in inflammation and sepsis. J. Intern. Med. 255, 320–331 (2004)
- Wei F., Yang D., Tewary P., Li Y., Li S., Chen X., Howard O.M., Bustin M., Oppenheim J.J.: The alarmin HMGN1 contributes to antitumor immunity and is a potent immunoadjuvant. Can. Res. 74, 5989–5998 (2014)
- West A.P., Koblansky A.A., Ghosh S.: Recognition and signaling by toll-like receptors. Annu. Rev. Cell Dev. Biol. 22, 409–437 (2006)
- Weyd H., Abeler-Dörner L., Linke B., Mahr A., Jahndel V., Pfrang S., Schnölzer M., Falk C.S., Krammer P.H.: Annexin A1 on the surface of early apoptotic cells suppresses CD8+ T cell immunity. Plos One, 8, e62449 (2013)
- Vacchelli E., Kroemer G. i wsp.: Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1. Science, 350, 972–978 (2015)
- Vance R.E.: A Copernican revolution? Doubts about the danger theory. J. Immunol. 165, 1725–1728 (2010)
- Vandenabeele P., Galluzzi L., Vanden Berghe T., Kroemer G.: Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat. Rev. Mol. Cell Biol.11, 700–714 (2010)
- Yang D., Han Z., Oppenheim J.J.: Alarmins and immunity. Immunol. Rev. 280, 41–56 (2017)
- Yang D., Oppenheim J.J. i wsp.: High-mobility group nucleosome-binding protein 1 acts as an alarmin and is critical for lipopolysaccharide-induced immune responses. J. Exp. Med.209, 157–171 (2012)
- Yang D., Biragyn A., Hoover D.M., Lubkowski J., Oppenheim J.J.: Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu. Rev. Immunol. 22, 181–315 (2004)
- Yang D., Bustin M., Oppenheim J.J.: Harnessing the alarmin HMGN1 for anticancer therapy. Immunotherapy, 7, 1129–1131 (2015)
- Yang D., Chen Q,. Schmidt A.P., Anderson G.M., Wang J.M., Wooters J., Oppenheim J.J., Chertov O.: LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J. Exp. Med. 192, 1069–1074 (2000)
- Yao Y.M., Redl H., Bahrami S., Schlag G.: The inflammatory basis of trauma/shock-associated multiple organ failure. Inflamm. Res. 47, 201–210 (1998)
- Yendamuri S., Fulda G.J., Tinkoff G.H.: Admission hyperglycemia as a prognostic indicator in trauma. J. Trauma, 55, 33–38 (2003)
- Yoon K.W., Lee S.W. i wsp.: Control of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53. Science, 349, 1261669 (2015)
- Zhang Q., Itagaki K., Hauser C.J.: Mitochondrial DNA is released by shock and activates neutrophils via P38 map kinase. Shock, 34, 55–59 (2010)
- Zhou J., Hodi F.S. i wsp.: Soluble PD-L1 as a biomarker in malignant melanoma and checkpoint blockade. Cancer Immunol. Res. 5, 480–492 (2017)
- Zhou R., Tardivel A., Thorens B., Choi I., Tschopp J.: Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol.11, 136–140 (2010)